152 related articles for article (PubMed ID: 23328787)
1. CD30+ lymphomatoid drug reactions.
Pulitzer MP; Nolan KA; Oshman RG; Phelps RG
Am J Dermatopathol; 2013 May; 35(3):343-50. PubMed ID: 23328787
[TBL] [Abstract][Full Text] [Related]
2. Erythematous-to-brownish plaques on the upper back: a quiz. Phenytoin-induced T-cell predominant pseudolymphoma (“pseudomycosis fungoides”) with T-cell clonality.
Toberer F; Hartschuh W; Kutzner H; Flux K
Acta Derm Venereol; 2015 Mar; 95(3):378-82. PubMed ID: 25111894
[No Abstract] [Full Text] [Related]
3. Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates: a hypothesis.
Magro CM; Crowson AN
Hum Pathol; 1996 Feb; 27(2):125-32. PubMed ID: 8617453
[TBL] [Abstract][Full Text] [Related]
4. An instructive case of amlodipine-induced reversible granulomatous CD30
Cheong KW; Lim GZ; Tan KB; Lim JH
Australas J Dermatol; 2020 Aug; 61(3):e346-e350. PubMed ID: 31965571
[TBL] [Abstract][Full Text] [Related]
5. CD30-positive T-cell pseudolymphoma induced by amlodipine.
Kabashima R; Orimo H; Hino R; Nakashima D; Kabashima K; Tokura Y
J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1522-4. PubMed ID: 18452522
[No Abstract] [Full Text] [Related]
6. Drug-induced CD30+ T cell pseudolymphoma.
Fukamachi S; Sugita K; Sawada Y; Bito T; Nakamura M; Tokura Y
Eur J Dermatol; 2009; 19(3):292-4. PubMed ID: 19336342
[No Abstract] [Full Text] [Related]
7. Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption.
Sawada Y; Yoshiki R; Kawakami C; Fukamachi S; Sugita K; Nakamura M; Tokura Y
Acta Derm Venereol; 2010 Sep; 90(5):521-2. PubMed ID: 20814632
[No Abstract] [Full Text] [Related]
8. CD30 Positive Lymphomatoid Angiocentric Drug Reactions: Characterization of a Series of 20 Cases.
Magro CM; Olson LC; Nguyen GH; de Feraudy SM
Am J Dermatopathol; 2017 Jul; 39(7):508-517. PubMed ID: 27655118
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine-associated CD8+ CD30+ pseudolymphoma.
Marucci G; Sgarbanti E; Maestri A; Calandri C; Collina G
Br J Dermatol; 2001 Oct; 145(4):650-2. PubMed ID: 11703296
[TBL] [Abstract][Full Text] [Related]
10. CD30-positive T-cell-rich pseudolymphoma induced by gold acupuncture.
Kim KJ; Lee MW; Choi JH; Sung KJ; Moon KC; Koh JK
Br J Dermatol; 2002 May; 146(5):882-4. PubMed ID: 12000389
[TBL] [Abstract][Full Text] [Related]
11. Acute generalized exanthematous pustulosis with histopathologic findings of lymphomatoid drug reaction.
Llamas-Velasco M; Godoy A; Sánchez-Pérez J; García-Diez A; Fraga J
Am J Dermatopathol; 2013 Aug; 35(6):690-1. PubMed ID: 23291582
[No Abstract] [Full Text] [Related]
12. CD30 antigen expression in cutaneous inflammatory infiltrates of scabies: a dynamic immunophenotypic pattern that should be distinguished from lymphomatoid papulosis.
Gallardo F; Barranco C; Toll A; Pujol RM
J Cutan Pathol; 2002 Jul; 29(6):368-73. PubMed ID: 12135469
[TBL] [Abstract][Full Text] [Related]
13. Drug induced pseudolymphoma.
Magro CM; Daniels BH; Crowson AN
Semin Diagn Pathol; 2018 Jul; 35(4):247-259. PubMed ID: 29361381
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE.
Brady SP; Magro CM; Diaz-Cano SJ; Wolfe HJ
Hum Pathol; 1999 Feb; 30(2):130-6. PubMed ID: 10029439
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine-induced pseudolymphoma with CD-30 positive cells.
Nathan DL; Belsito DV
J Am Acad Dermatol; 1998 May; 38(5 Pt 2):806-9. PubMed ID: 9591791
[TBL] [Abstract][Full Text] [Related]
16. Stenotrophomonas maltophilia skin infection in an immunocompetent patient: Primary cutaneous CD30+ T-cell lymphoproliferative disorder or pseudolymphoma?
Prete MD; Scarabello A; Lora V; Cota C
J Cutan Pathol; 2024 Jun; 51(6):403-406. PubMed ID: 38419370
[TBL] [Abstract][Full Text] [Related]
17. Interstitial granulomatous dermatitis associated with gabapentin.
Georgesen C; McDonough P; Cruz P
Dermatitis; 2014; 25(6):374-5. PubMed ID: 25384220
[No Abstract] [Full Text] [Related]
18. CD30-positive Cutaneous Pseudolymphoma Caused by Tocilizumab in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.
Inoue A; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
Acta Derm Venereol; 2016 May; 96(4):570-1. PubMed ID: 26631390
[No Abstract] [Full Text] [Related]
19. Histopathological Spectrum and Immunophenotypic Characterization of Symmetrical Drug-Related Intertriginous and Flexural Exanthema.
Muresan AM; Metze D; Böer-Auer A; Braun SA
Am J Dermatopathol; 2021 Feb; 43(2):103-111. PubMed ID: 32618703
[TBL] [Abstract][Full Text] [Related]
20. Lymphoma- and leukemia-associated cutaneous atypical CD30+ T-cell reactions.
Su LD; Duncan LM
J Cutan Pathol; 2000 May; 27(5):249-54. PubMed ID: 10847550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
